Risk of congenital anomalies in infants born to women with autoimmune disease using biologics before or during pregnancy: a population-based cohort study.

Tsao, Nicole W; Hanley, Gillian E; Lynd, Larry D; Amiri, Neda; De Vera, Mary A

Tsao, Nicole W; Hanley, Gillian E; Lynd, Larry D; Amiri, Neda; De Vera, Mary A.

Affiliation

Tsao NW; University of British Columbia Faculty of Pharmaceutical Sciences, Vancouver; Collaboration for Outcomes Research and Evaluation, Vancouver; and Arthritis Research Canada, Richmond, Canada.
Hanley GE; University of British Columbia Faculty of Medicine, Department of Obstetrics & Gynecology, Vancouver, Canada.
Lynd LD; University of British Columbia Faculty of Pharmaceutical Sciences, Vancouver; Collaboration for Outcomes Research and Evaluation, Vancouver; Centre for Health Evaluation & Outcomes Sciences, Vancouver, Canada.
Amiri N; University of British Columbia Faculty of Medicine, Department of Medicine, Division of Rheumatology, Vancouver, Canada.
De Vera MA; University of British Columbia Faculty of Pharmaceutical Sciences, Vancouver; Collaboration for Outcomes Research and Evaluation, Vancouver; and Arthritis Research Canada, Richmond, Canada. mary.devera@mail.ubc.ca.

Clin Exp Rheumatol ; 37(6): 976-982, 2019.

Article in En | MEDLINE | ID: mdl-30943142

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Autoimmune Diseases / Congenital Abnormalities / Biological Products / Pregnant Women Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Newborn / Pregnancy Country/Region as subject: America do norte Language: En Journal: Clin Exp Rheumatol Year: 2019 Document type: Article Affiliation country: Country of publication:

Search on Google

Add to My VHL

XML

PubMed Links